Open AccessMYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer
Author(s) -
Meng Ji,
Facai Zhang,
Wei Teng,
Chengjun Zhou
Publication year - 2022
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s351638
Subject(s) - medicine , kegg , immune system , prostate cancer , gene expression profiling , oncology , bioinformatics , immunology , cancer , gene expression , gene , biology , genetics , transcriptome
MYB proto-oncogene like 2 (MYBL2) is a member of the MYB family of transcription factor genes and overexpressed in many cancers. We investigated the role of MYBL2 in the malignant progression of prostate cancer (PCa) and its relationship with immune infiltrates in PCa.